The effect of versican G3 domain on local breast cancer invasiveness and bony metastasis
2007

The Role of Versican G3 Domain in Breast Cancer Invasiveness and Metastasis

Sample size: 15 publication 10 minutes Evidence: moderate

Author Information

Author(s): Yee Albert JM, Akens Margarete, Yang Bing L, Finkelstein Joel, Zheng Peng-Sheng, Deng Zhaoqiong, Yang Burton

Primary Institution: University of Toronto, Sunnybrook Health Sciences Centre

Hypothesis

The G3 domain of versican influences local tumor invasiveness in breast cancer and systemic invasiveness to bone and soft tissues.

Conclusion

Versican G3 domain is important in enhancing local and systemic tumor invasiveness in human breast cancer.

Supporting Evidence

  • Greater viability of cancer cells was observed in low serum and serum-free conditions in the presence of versican G3.
  • Larger subcutaneous tumors were obtained in the G3 group following tumor cell injection into CD1 mice.
  • G3 induced a greater degree of rodent vascular endothelial cell proliferation and migration in vitro.
  • Systemic tumor burden to distant bony and soft tissue metastatic sites was greater in the G3 group.

Takeaway

This study found that a part of a protein called versican helps breast cancer cells grow and spread more easily, especially to bones.

Methodology

The study involved in vitro and in vivo experiments using human breast carcinoma MT-1 cells and a rodent model to evaluate tumor growth and metastasis.

Limitations

The intracardiac injection model bypasses the initial establishment of a local tumor, which may not reflect the physiological process of metastasis.

Participant Demographics

Female nude rats aged 5-7 weeks were used in the study.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/bcr1751

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication